On the stock market since 1981, it operates in the world of technology. It has 39 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 9% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
An investor who bought at the very peak is down 80% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $71.9M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 5 buys and 1 sell. Management buying with its own money is usually read as a good sign.
It pays out $61.07 per share each year — regular cash for whoever holds the stock.
A loss of $10.9M against $71.9M in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, JCS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: JCS is a high-risk stock — not yet profitable, and its future rides on its product catching on.